Fifty Years of Research on European Mink L., 1761 Genetics: Where Are We Now in Studies on One of the Most Endangered Mammals?

Genes (Basel)

Institute of Marine and Environmental Sciences, University of Szczecin, Adama Mickiewicza 16 St., 70-383 Szczecin, Poland.

Published: November 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The purpose of this review is to present the current state of knowledge about the genetics of European mink L., 1761, which is one of the most endangered mammalian species in the world. This article provides a comprehensive description of the studies undertaken over the last 50 years in terms of cytogenetics, molecular genetics, genomics (including mitogenomics), population genetics of wild populations and captive stocks, phylogenetics, phylogeography, and applied genetics (including identification by genetic methods, molecular ecology, and conservation genetics). An extensive and up-to-date review and critical analysis of the available specialist literature on the topic is provided, with special reference to conservation genetics. Unresolved issues are also described, such as the standard karyotype, systematic position, and whole-genome sequencing, and hotly debated issues are addressed, like the origin of the Southwestern population of the European mink and management approaches of the most distinct populations of the species. Finally, the most urgent directions of future research, based on the research questions arising from completed studies and the implementation of conservation measures to save and restore populations, are outlined. The importance of the popularization of research topics related to European mink genetics among scientists is highlighted.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696698PMC
http://dx.doi.org/10.3390/genes11111332DOI Listing

Publication Analysis

Top Keywords

european mink
16
mink 1761
8
genetics
8
conservation genetics
8
fifty years
4
european
4
years european
4
mink
4
1761 genetics
4
genetics studies
4

Similar Publications

Objective: To develop a set of pediatric neurocritical care (PNCC) entrustable professional activities (EPAs) for pediatric critical care medicine (PCCM).

Design: Survey and Delphi methodology in a panel of experts from the Pediatric Neurocritical Care Research Group (PNCRG) and the Education in Pediatric Intensive Care (EPIC) Research Collaborative.

Setting: Interprofessional local focus group, national focus group, and subsequent national multi-institutional, multidisciplinary expert panel in the United States.

View Article and Find Full Text PDF

Exercise intensity plays a critical role in influencing immune responses during myocarditis, a condition characterized by inflammation of the cardiac tissue. Based on preclinical and clinical evidence, this review examines how moderate high-intensity training affects immune activation in myocarditis. Studies involving animals suggest that moderate exercise may reduce inflammation and support immune regulation, while high-intensity training often exacerbates pro-inflammatory responses and worsens cardiac injury.

View Article and Find Full Text PDF

An Online Buffer Exchange Platform for Charge Detection Mass Spectrometry Analysis of AAVs and AAV-Antibody Complexes.

J Am Soc Mass Spectrom

September 2025

Analytical Chemistry Group, Regeneron Pharmaceuticals Inc., Tarrytown, New York 10591, United States.

Adeno-associated viruses (AAVs) are leading vectors in gene therapy that have demonstrated great potential in combating a wide range of human diseases. To enhance specificity and reduce dosing requirements, antibody-retargeted AAVs have emerged as a promising strategy to redirect vectors to novel receptors, thereby achieving improved efficacy and safety. However, effective characterization of AAVs and AAV-antibody complexes is complicated by heterogeneities that arise from variations in capsid protein assembly, genome integrity, and antibody decorations, demanding high-resolution techniques beyond traditional methods.

View Article and Find Full Text PDF

Nonacog beta pegol (N9-GP) is a glycoPEGylated FIX replacement product with extended half-life for treatment of haemophilia B patients. Monitoring of N9-GP with clotting-based one-stage FIX assays is complicated by high variations, mainly due to reagent-specific interference with polyethylene glycol.In 11 distinct specialized coagulation laboratories in Austria, N9-GP spiked samples were measured in replicates in two distinct surveys, 3 years apart, using five different one-stage assay reagents and one chromogenic FIX assay.

View Article and Find Full Text PDF